On August 20, 2020 Moffitt Cancer Ctr reported that World-renowned tumor immunologist Patrick Hwu, M.D., has been appointed the new president and CEO of Moffitt Cancer Center (Press release, Moffitt Cancer Ctr, AUG 20, 2020, View Source [SID1234563959]). He joins Moffitt from The University of Texas MD Anderson Cancer Center, where he is the division head of Cancer Medicine. Hwu begins his new role at Moffitt on Nov. 10.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Patrick Hwu, M.D., president and CEO, Moffitt Cancer CenterPatrick Hwu, M.D., president and CEO, Moffitt Cancer Center
"Dr. Hwu is truly a cancer visionary ready to elevate Moffitt to even greater success," said Tim Adams, chair of Moffitt’s Institute Board of Directors. "Drawing from his innovative cancer research, quality patient care and extensive leadership experience, Dr. Hwu will no doubt continue to help Moffitt in our pursuit of dynamic growth and groundbreaking work."
"It is my distinct honor and privilege to be selected as the next president and CEO of Moffitt Cancer Center, which has made unprecedented strides in its 34 years in the prevention and treatment of cancer," Hwu said. "I look forward to bringing my years of experience as a cancer physician, researcher and leader to help advance the outstanding work already underway by the teams of cancer experts at Florida’s top-ranked cancer hospital. I’m confident that our collective efforts will further elevate Moffitt’s leadership in cancer patient care, research and education."
Hwu brings 33 years of oncology experience to Moffitt. He held various leadership roles during 17 years at MD Anderson, including chair of the Department of Sarcoma Medical Oncology and co-director of the Center for Cancer Immunology Research. He was the first chair of the Department of Melanoma Medical Oncology. Known for leading transformative research into the clinic, Hwu helped pioneer the field of gene modified T cells, publishing research on the first chimeric antigen receptor directed against cancer. His work focuses on vaccines, adoptive T-cell therapies and immune resistance. He is the principal investigator on a National Institutes of Health SPORE grant for melanoma and has more than 270 peer-reviewed publications.
Hwu is vice president/president elect at the Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper), serves on the Melanoma Research Alliance Foundation Medical Advisory Panel in Washington, D.C., and is a member of numerous scientific advisory boards throughout the U.S.
Founder H. Lee MoffittFounder H. Lee Moffitt
"Dr. Patrick Hwu is a nationally respected physician-scientist with the vision to lead Moffitt into the future," said founder H. Lee Moffitt. "Coming from the largest cancer center in the country, where he has distinguished himself and produced incredible results, we expect he will successfully guide the Moffitt team through the next generation of cancer treatments and discoveries.
"I’m confident Dr. Hwu will inspire and continue our mission to contribute to the prevention and cure of cancer. Our impact on helping cancer patients will be felt worldwide and, in the process, continue to make Florida proud," Moffitt said.
Russell Reynolds Associates, a global leadership advisory and search firm, led the extensive and competitive national search.
Hwu earned his medical degree from The Medical College of Pennsylvania. He served as a house officer in Internal Medicine at The Johns Hopkins Hospital and completed a fellowship in oncology at the National Cancer Institute.